My compounded semaglutide provider shut down. Where should I move my treatment?

Sorry that happened — that’s stressful. You’ll want to move from compounded semaglutide to an FDA‑approved product and a licensed prescriber so you get consistent dosing, safety monitoring, and reliable supply. Here’s a practical plan and specific options:

Why switch to an FDA‑approved product

• Compounded semaglutide can have variable potency and contamination risk. FDA‑approved drugs are manufactured and labeled to consistent standards.
• FDA‑approved options: Ozempic (semaglutide injection) — for type 2 diabetes; Wegovy (semaglutide injection) — higher dose FDA‑approved for chronic weight management; Rybelsus (oral semaglutide) — oral option for type 2 diabetes. Which is appropriate depends on your diagnosis and goals.

Where to get a new prescription

1. Your primary care physician or an endocrinologist

   • Best for continuity of care and lab monitoring (A1c, kidney function, etc.). Ask for a prescription for an FDA‑approved product (Ozempic/Wegovy/Rybelsus) rather than a compounded version.

2. Telemedicine clinics that commonly handle GLP‑1 care (availability varies by state and medical eligibility)

   • Ro (Roman) — offers GLP‑1 evaluation and ongoing care programs.
   • Hims & Hers — telehealth weight‑management programs with GLP‑1 prescribing.
   • PlushCare — primary care/telehealth that can evaluate and prescribe GLP‑1s.
   • One Medical — membership primary care with in‑person/virtual visits and chronic care follow‑up.
   • SteadyMD — ongoing remote primary care that may manage GLP‑1 therapy. Note: each service assesses medical history and will only prescribe if clinically appropriate.

3. Specialty/obesity clinics

   • Look for clinics with board‑certified endocrinologists or physicians certified in obesity medicine (examples: local university medical centers, Cleveland Clinic, Mayo Clinic weight‑management programs). They can tailor dose and monitoring.

Where to fill the prescription

• Use major retail pharmacies and specialty pharmacies to ensure legitimate product and cold‑chain handling: CVS, Walgreens, Walmart, or specialty pharmacies such as Accredo, OptumRx, or your insurer’s specialty pharmacy.
• Manufacturer patient support: Novo Nordisk offers savings programs and patient support for Ozempic/Wegovy — ask about coupons or copay assistance if cost is a concern.
• Use GoodRx or your insurer’s formulary to compare prices, but avoid unknown online pharmacies or overseas sources.

Practical steps to take now

• Get your medication records (dose, frequency, lot number if you have it) from the compounding provider if possible.
• Contact your PCP or an endocrinologist (or a telehealth service above) and request transition to an FDA‑approved semaglutide product. Bring/attach past dosing info.
• Ask what baseline labs or monitoring they want (A1c, renal function, pregnancy test if applicable).
• Fill the Rx at a major retail or specialty pharmacy; confirm storage instructions and injection technique.
• Arrange follow‑up within 4–12 weeks to review response and side effects.

Safety notes

• Report any adverse effects you had with the compounded product to your new prescriber and to FDA MedWatch if you suspect contamination or serious harm.
• Don’t try to match doses 1:1 without clinical input — the concentration/volume may differ and dosing protocols for Wegovy vs Ozempic differ.
• If you’re pregnant, planning pregnancy, or have a history of medullary thyroid carcinoma or pancreatitis, let the prescriber know — some GLP‑1s are contraindicated.

If you’d like, I can:

• Help find nearby endocrinologists or obesity clinics if you tell me your ZIP code or city.
• Draft a short message you can send to a new prescriber summarizing your prior treatment and what you need.